ArticlePopulation health management2026
Cervical Cancer and Sexually Transmitted Infections Screening Among Individuals with a Substance Use Disorder: A Retrospective Cohort Study.
Article in Population health management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Substance use disorders (SUDs) have been associated with barriers to preventive medicine screening, but little is known about the association of SUDs and cervical cancer and sexually transmitted infections (STIs) screening rates. This retrospective cohort study used de-identified medical records to select women aged 31-59 as of January 1, 2019. Logistic regression models were computed to estimate the association between any SUDs, including alcohol, compared to no SUD diagnoses, and odds of cervical cancer and STIs screening during the observation period (2019-2024) before and after controlling for covariates. The final cohort included 315,748 people with an average age of 39.4 (±11.6) years old, of whom 22,343 had SUDs. Eighty-two percent were White, and 12.6% were Black individuals. During the 6-year follow-up period, 41% of the cohort received a cervical cancer screening test. After controlling for covariates, individuals with SUDs were less likely to receive cervical cancer screening compared to those without SUDs (odds ratio [OR] = 0.95; 95% confidence interval [CI]: 0.92-0.98). Opioid and sedative use disorders were significantly associated with lower odds of cervical cancer screening (OR = 0.86; 95% CI: 0.81-0.92 and OR = 0.85; 95% CI: 0.72-0.99, respectively). Individuals with SUDs were more likely to receive STI screen compared with those without SUDs (OR = 1.08; 95% CI: 1.05-1.12). An SUD diagnosis is a modest barrier to cervical cancer screening and is associated with more STI screening. Health care professionals must work with multidisciplinary teams to identify and address these barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.